STOCK TITAN

Ascend Wellness Stock Price, News & Analysis

AAWH OTC

Welcome to our dedicated page for Ascend Wellness news (Ticker: AAWH), a resource for investors and traders seeking the latest updates and insights on Ascend Wellness stock.

Ascend Wellness Holdings (AAWH) is a vertically integrated cannabis operator with cultivation, manufacturing, and retail facilities across seven U.S. states. This page provides investors and industry stakeholders with timely updates on corporate developments, financial performance, and market positioning.

Access official press releases and third-party analysis covering earnings reports, regulatory compliance milestones, product launches, and strategic partnerships. Our curated collection simplifies tracking AAWH's growth in medical and adult-use cannabis markets while maintaining strict compliance with financial disclosure standards.

Key updates include expansion announcements, operational efficiency improvements, and leadership changes. All content is verified for accuracy and relevance to support informed analysis of this multi-state operator's market trajectory.

Bookmark this page for streamlined access to AAWH's evolving story in the competitive cannabis sector. Check regularly for new developments impacting the company's operational footprint and industry standing.

News
Rhea-AI Summary

AWH ANNOUNCES Q1 2024 FINANCIAL RESULTS: Ascend Wellness Holdings, Inc. reported $142.4M Net Revenue in Q1 2024, a 25% YoY increase and 2% QoQ increase. Adjusted EBITDA was $32.5 million, a 39% YoY increase. The company generated positive cash flow. Retail revenue increased 15.1% YoY. Net loss was $18.2 million. Cash and cash equivalents were $72.9 million. AWH opened two dispensaries, secured operating agreements with two partner dispensaries, and operationalized a new facility. The company plans revenue growth of 12-15% and adjusted EBITDA increase of 17-22% compared to 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.94%
Tags
-
Rhea-AI Summary

Ascend Wellness Holdings, Inc. (AWH) supports the DEA's decision to move cannabis from Schedule I to Schedule III of the CSA, marking a significant step in cannabis reform. This change is expected to bring benefits like tax relief, improved access, funding opportunities, research advancements, and potential up-listing for AWH. The company looks forward to further developments and celebrates the decision's positive impact on stakeholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.29%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.47%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.7%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.89%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.27%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.51%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.11%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
none

FAQ

What is the current stock price of Ascend Wellness (AAWH)?

The current stock price of Ascend Wellness (AAWH) is $0.852 as of October 13, 2025.

What is the market cap of Ascend Wellness (AAWH)?

The market cap of Ascend Wellness (AAWH) is approximately 140.2M.
Ascend Wellness

OTC:AAWH

AAWH Rankings

AAWH Stock Data

140.18M
123.87M
29.61%
11.53%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Morristown